So if i'm understanding this correctly, the PFS has been completed on the basis of LCK securing funding for the project themselves; or, at the least that it's project projections in this PFS are conducted w/o a commercial partner considered. Which if so, stacks up very well as an option for commercialisation (so long as they can secure the funding), it would seem that any other option where a commercial partner fronts capital for the project, then taking the lion's share of profit would be comparatively less value to shareholders.
This seems to make sense given in the PFS ann, they refer to negotiations with offtake partner's.. the dialogue is shifting from commercialisation partners.
If LCK secured their own project financing for this, LCK share value would see exponential growth.
- Forums
- ASX - By Stock
- NRZ
- Ann: Pre-Feasibility Study Presentation
Ann: Pre-Feasibility Study Presentation, page-2
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NRZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.724M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NRZ (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online